AKARI THERAPEUTICS PLC's ticker is AKTX and the CUSIP is 00972G108. A total of 11 filers reported holding AKARI THERAPEUTICS PLC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $115,000 | -81.4% | 58,770 | -82.7% | 0.00% | -80.0% |
| Q1 2018 | $618,000 | -79.5% | 339,833 | -51.2% | 0.01% | -80.8% |
| Q4 2017 | $3,018,000 | -1.1% | 696,901 | +40.2% | 0.03% | +4.0% |
| Q3 2017 | $3,051,000 | +33.2% | 496,901 | 0.0% | 0.02% | +25.0% |
| Q2 2017 | $2,291,000 | -58.4% | 496,901 | 0.0% | 0.02% | -55.6% |
| Q1 2017 | $5,501,000 | +57.3% | 496,901 | 0.0% | 0.04% | +32.4% |
| Q4 2016 | $3,498,000 | -17.3% | 496,901 | 0.0% | 0.03% | -10.5% |
| Q3 2016 | $4,229,000 | -36.9% | 496,901 | 0.0% | 0.04% | -45.7% |
| Q2 2016 | $6,703,000 | +20.9% | 496,901 | +25.5% | 0.07% | +20.7% |
| Q1 2016 | $5,542,000 | -3.4% | 395,882 | 0.0% | 0.06% | +20.8% |
| Q4 2015 | $5,740,000 | -39.6% | 395,882 | 0.0% | 0.05% | -45.5% |
| Q3 2015 | $9,499,000 | – | 395,882 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 7,941,867 | $1,443,037 | 1.26% |
| Omnia Family Wealth, LLC | 782,372 | $142,157 | 0.11% |
| NEA Management Company, LLC | 452,167 | $82,159 | 0.01% |
| Hikari Power Ltd | 130,821 | $24 | 0.00% |
| Bryn Mawr Capital Management, LLC | 100,000 | $18,170 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 30,264 | $5,495 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 261,192 | $47 | 0.00% |
| Renaissance Technologies | 283,550 | $52 | 0.00% |
| LPL Financial LLC | 134,453 | $24,430 | 0.00% |
| JPMORGAN CHASE & CO | 237 | $0 | 0.00% |